---
figid: PMC9406959__cells-11-02530-g002
figtitle: Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling
  Pathways in Glioblastoma
organisms:
- Lareunionomyces loeiensis
- Allium sativum
- Marchantiophyta
- Veratrum californicum
- Rhodiola crenulata
- Apopellia endiviifolia
- Anthriscus cerefolium
- Ononis spinosa
- Phlomis fruticosa
- Canis lupus familiaris
- Ovis aries
- Paraechinus aethiopicus
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Caenorhabditis elegans
- Homo sapiens
- Adeno-associated virus
pmcid: PMC9406959
filename: cells-11-02530-g002.jpg
figlink: /pmc/articles/PMC9406959/figure/cells-11-02530-f002/
number: F2
caption: The canonical activation of HH pathway and its pharmaceutical inhibitors.
  The activation of pathway occurs when HH ligand binds to PTCH at the cell membrane.
  In response to this binding, PTCH no longer inhibits SMO and initiates the downstream
  signaling, causing rapid dissociation of the SuFu–GLI complex and thus allowing
  GLI to enter the nucleus and regulate transcription of target genes. Proven pharmacological
  inhibitors that target SHH signaling components (SMO receptor or GLI transcription
  factors) are presented in red. References are included in the main text.
papertitle: Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling
  Pathways in Glioblastoma.
reftext: Danijela Drakulic, et al. Cells. 2022 Aug;11(16):2530.
year: '2022'
doi: 10.3390/cells11162530
journal_title: Cells
journal_nlm_ta: Cells
publisher_name: MDPI
keywords: glioblastoma | GBM subtypes | SHH signaling | Wnt/β-catenin signaling |
  Notch signaling | TGFβ signaling | BMP signaling | Hippo signaling | RA signaling
automl_pathway: 0.9519224
figid_alias: PMC9406959__F2
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Ovis aries
- Mus musculus
- Canis lupus familiaris
- Drosophila melanogaster
redirect_from: /figures/PMC9406959__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9406959__cells-11-02530-g002.html
  '@type': Dataset
  description: The canonical activation of HH pathway and its pharmaceutical inhibitors.
    The activation of pathway occurs when HH ligand binds to PTCH at the cell membrane.
    In response to this binding, PTCH no longer inhibits SMO and initiates the downstream
    signaling, causing rapid dissociation of the SuFu–GLI complex and thus allowing
    GLI to enter the nucleus and regulate transcription of target genes. Proven pharmacological
    inhibitors that target SHH signaling components (SMO receptor or GLI transcription
    factors) are presented in red. References are included in the main text.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ptch1
  - Sufu
  - Kif7
  - Gli1
  - Smo
  - Gli2
  - Gli3
  - PTCH1
  - SUFU
  - KIF7
  - GLI1
  - SMO
  - SMOX
  - GLI2
  - GLI3
  - Smox
  - ptc
  - hh
  - Su(fu)
  - cos
  - Gli
  - ci
  - smo
  - sm
---
